European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.14% to 1,959.77 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and petroleum refiner Equinor (EQNR), which advanced 17% and 3.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion (EVAX), which rose 3.6% and 2.3% respectively.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and internet advertising firm Criteo (CRTO), which fell 3.4% and 2.3% respectively. They were followed by accommodations booking site trivago (TRVG) and brewing company Anheuser-Busch InBev (BUD), which were down 1.7% and 1.3% respectively.
The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which surged 43% and 7.7% respectively. They were followed by oil and gas company BP (BP) and biotech firm Trinity Biotech (TRIB), which increased 2.1% and 1.9% respectively.
The decliners from the UK and Ireland were led by communications company WPP (WPP) and tobacco company British American Tobacco (BTI), which lost 5.5% and 3.7% respectively. They were followed by telecommunications operator Vodafone Group (VOD), which was off 2.6%.